|Bid||5.68 x N/A|
|Ask||5.72 x N/A|
|Day's range||5.50 - 5.72|
|52-week range||3.35 - 6.39|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||14.41|
|Earnings date||26 Aug 2021|
|Forward dividend & yield||0.24 (4.62%)|
|Ex-dividend date||25 Mar 2022|
|1y target est||5.87|
Insiders who bought Australian Clinical Labs Limited ( ASX:ACL ) stock in the last 12 months were richly rewarded last...
Australian Clinical Labs (ASX:ACL) has had a rough week with its share price down 4.2%. However, stock prices are...
If you want to know who really controls Australian Clinical Labs Limited ( ASX:ACL ), then you'll have to look at the...